What investor type does SPDR S&P Biotech ETF fit best in FoxScore?

SPDR S&P Biotech ETF fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.

How meaningful is the available history for SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for SPDR S&P Biotech ETF

XBI · As of: 02/17/2026

Basic information

Type: ETF

Region: US

Sector: Biotechnology

TER: –

History

Available history:15.0 years

Last tradingday:02/17/2026

Description & usage

The SPDR S&P Biotech ETF provides industry-focused exposure to U.S. biotechnology companies. It holds firms developing biotech drugs, therapies and platform technologies, often centered on research and clinical development. Revenue can come from product sales, partnerships, licensing or research-related payments depending on company maturity, serving health care markets. Performance reflects stock price movements and captures the dynamics of the biotech sector in a single ETF.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

SPDR S&P Biotech ETF (XBI) currently has a total score of 51 points, placing it in the neutral range. The score is made up of Performance (45), Stability (51) and Trend (68).

Performance scores 45 points (neutral). Key strength: 1Y return at 36.6 %. Weaker metric: 5Y return at -27.9 %. This points to a sharper upswing more recently.

Stability scores 51 points (neutral). Key strength: Sortino ratio (90d) at 2.59. Weaker metric: max drawdown (3Y) at -63.1 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 68 points (strong). Key strength: trend strength at 0.90. Main drag: Price is about 0.4 % below SMA50.

Overall, the score is shaped most by Trend; Performance trails and dampens the total. On a metric level, trend strength stands out, while 5Y return lags.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

neutral

Scores

Metrics

FAQ

What investor type does SPDR S&P Biotech ETF fit best in FoxScore?: SPDR S&P Biotech ETF fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
How meaningful is the available history for SPDR S&P Biotech ETF?: SPDR S&P Biotech ETF currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.